Acadia Healthcare (NASDAQ: ACHC) reported Q4 EPS of $0.67, $0.08 worse than the analyst estimate of $0.75. Revenue for the quarter came in at $675.3 million versus the consensus estimate of $660.39 million.

GUIDANCE:

Acadia Healthcare sees FY2023 EPS of $3.10-$3.40, versus the consensus of $3.31. Acadia Healthcare sees FY2023 revenue of $2.82-2.88 billion, versus the consensus of $2.83 billion.

Acadia Healthcare sees Q1 2023 EPS of $0.70-$0.74, versus the consensus of $0.73. Acadia Healthcare sees Q1 2023 revenue of $690-700 million, versus the consensus of $674 million.

For earnings history and earnings-related data on Acadia Healthcare (ACHC) click here.